| CIHCX | OAYIX | CIHCX / OAYIX | |
| Total Expense Ratio | 2.00 | 0.89 | 225% |
| Annual Report Gross Expense Ratio | 2.22 | 0.89 | 249% |
| Fund Existence | 21 years | 10 years | - |
| Gain YTD | 13.069 | 5.401 | 242% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 445M | 12.8B | 3% |
| Annual Yield % from dividends | 2.66 | 1.88 | 142% |
| Returns for 1 year | 18.03 | 11.63 | 155% |
| Returns for 3 years | 61.56 | 40.44 | 152% |
| Returns for 5 years | 54.99 | 30.60 | 180% |
| Returns for 10 years | 101.31 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NASDX | 52.85 | 0.47 | +0.90% |
| Shelton Nasdaq-100 Index Investor | |||
| ECHSX | 13.21 | N/A | N/A |
| Eaton Vance Worldwide Health Sci C | |||
| SVIIX | 10.48 | N/A | N/A |
| Virtus Ceredex Large-Cap Value Equity A | |||
| FCAGX | 38.20 | N/A | N/A |
| Fidelity Advisor Small Cap Growth A | |||
| ACMDX | 11.72 | N/A | N/A |
| Absolute Capital Defender Investor | |||